Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/27/2005US6979449 Acellular immunogenic compositions and acellular vaccine compositions against Bacillus anthracis
12/27/2005US6979448 Particles created by insertion of Mucin peptide epitopes into a plant virus (cowpea mosaic virus) with beta-barrel structure in its coat protein; good mucosal immunity with intranasal vaccine
12/27/2005US6979447 Immunomodulation and effect on cell processes relating to serotonin family receptors
12/27/2005US6979446 Monoclonal antibodies to the ClfA protein and method of use in treating or preventing infections
12/27/2005US6979443 Chemokine α-6
12/27/2005US6979442 granulocyte colony stimulating factor (G-CSF) and a stabilizing buffer; sustained release; for preventing or treating infections in mammals
12/27/2005CA2158018C Improved feedcrops enriched in sulfur amino acids and methods for improvement
12/27/2005CA2137280C Cloning of gene encoding the gp28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
12/22/2005WO2005121793A2 Detection of methamphetamine group drugs
12/22/2005WO2005121755A1 Cell free g-protein coupled receptor and ligand assay
12/22/2005WO2005121377A2 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase
12/22/2005WO2005121376A2 Hiv variants showing a novel resistance mechanism against protease inhibitors, diagnostic assays for detecting the variant, and methods for identifying drugs effective against the resistant variant
12/22/2005WO2005121364A2 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
12/22/2005WO2005121356A1 Novel screening method
12/22/2005WO2005121354A2 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
12/22/2005WO2005121342A1 Recombinant enterotoxin c and vaccine with the use of the same
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121339A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005WO2005121335A1 Episomal fusion gene
12/22/2005WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use
12/22/2005WO2005121175A2 Env polypeptide complexes and methods of use
12/22/2005WO2005121174A2 Novel g-csf polypeptides, polynucleotides, modulators thereof, and methods of use
12/22/2005WO2005121173A1 Method for purifying erythropoietin
12/22/2005WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005WO2005121171A1 Proteins stabilizing hydrophobic molecules
12/22/2005WO2005121170A1 Abc transporter protein that confers resistance to bacitracin in interococci
12/22/2005WO2005121169A2 Apoptosis-inducing polypeptides
12/22/2005WO2005121168A2 Heparin binding peptide
12/22/2005WO2005121167A1 Monocyte locomotion inhibitory factor
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005121165A1 Process for protein isolation
12/22/2005WO2005121163A2 Isolation of plasma or serum proteins
12/22/2005WO2005120588A2 Peptides delivered to cell nuclei
12/22/2005WO2005120583A2 Method for preventing or treating cardiac hypertrophy
12/22/2005WO2005120570A2 Therapeutic targeting of parc/ccl18 and its signaling in pulmonary fibrosis
12/22/2005WO2005120566A1 Dendrite cells transduced with recombinant adenovirus advcea which generate cea-specific cytotoxic t lymphocytes, vaccine and pharmaceutical composition comprising the same
12/22/2005WO2005120565A2 Sars vaccines and methods to produce highly potent antibodies
12/22/2005WO2005120564A2 Vaccine compositions and methods
12/22/2005WO2005120562A2 Structure-based receptor mimics targeted against bacterial superantigen toxins
12/22/2005WO2005120552A1 METHODS AND FORMULATIONS OF GnRH/LEUKOTOXIN CHIMERAS FOR TESTOSTERONE SUPPRESSION
12/22/2005WO2005120547A1 Use of neuregulin-3 for inducing mammary cell differentiation and for the treatment of breast cancer
12/22/2005WO2005120215A1 The shine clade of transcription factors and their use
12/22/2005WO2005120214A1 Markers for salinity tolerance in wheat plants and the use thereof in breeding programs
12/22/2005WO2005110454A8 Protective binding members of pyy for the treatment of metabolic disorders
12/22/2005WO2005103080A3 Stable oxidation resistant powdered hemoglobin, methods of preparing same, and uses thereof
12/22/2005WO2005095447A3 Low molecular weight forms of foxp1 proteins and splice variants thereof
12/22/2005WO2005094533A3 Trail-r as a negative regulator of innate immune cell responses
12/22/2005WO2005090394A3 Cyanide tolerant nitrilhydratases
12/22/2005WO2005082020A3 Flavivirus vaccines
12/22/2005WO2005079566A3 Gene disruptions, compositions and methods relating thereto
12/22/2005WO2005077003A3 Pili from mycobacterium tuberculosis
12/22/2005WO2005074972A3 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
12/22/2005WO2005069969A3 Mutant sodium channel nav1.7 and methods related thereto
12/22/2005WO2005066339A3 Polypeptides of alicyclobacillus sp.
12/22/2005WO2005063998A3 Maize metallothionein 2 promoter and methods of use
12/22/2005WO2005061537A3 Squamous cell carcinoma antigens and use thereof
12/22/2005WO2005049843A3 Plant cells and plants with increased resistance to stress
12/22/2005WO2004111074A3 In vivo production of a clostridial neurotoxin light chain peptide
12/22/2005WO2004094613A3 Polyvalent protein complex
12/22/2005WO2004093823A3 Polyethelene glycol link glp-1 compounds
12/22/2005WO2004087874A3 Novel nucleic acids and polypeptides
12/22/2005WO2004085621A3 Gene expression in breast cancer
12/22/2005WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits
12/22/2005WO2004072241A3 Compositions and methods for cleaving iap
12/22/2005WO2004070004A3 Rat receptor tyrosine kinase, kdr
12/22/2005WO2004044175A3 Fluorescence guided cell capture
12/22/2005WO2004041160A3 Methods and animal model for analyzing age-related macular degeneration
12/22/2005WO2004035535A3 Erythrocyte differentiation factor, gene encoding same, and methods of use thereof
12/22/2005WO2004027037A3 RECOVERY OF RECOMBINANT HUMAN PARAINFLUENZA VIRUS TYPE 2 (HPIV2) FROM cDNA AND USE OF RECOMBINANT HPIV2 IN IMMUNOGENIC COMPOSITIONS AND AS VECTORS TO ELICIT IMMUNE RESPONSES AGAINST PIV AND OTHER HUMAN PATHOGENS
12/22/2005WO2004022706A3 Immune cell receptor ligand and immune cell receptor
12/22/2005WO2004020610A3 Methods and compositions for modulating xbp-1 activity
12/22/2005WO2004011604A3 Nucleic acid-associated proteins
12/22/2005WO2003100000A3 Amplification and overexpression of oncogenes
12/22/2005WO2003092611A3 Methods of inducing formation of functional and organized lymphatic vessels
12/22/2005WO2003080796A3 Ordered biological nanostructures formed from chaperonin polypeptides
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002086060A3 Molecular sequence of pig endogenous retrovirus receptors and methods of use
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283858 Brassica AHAS genes and gene alleles that provide resistance to imidazolinone herbicides
12/22/2005US20050283857 Peptides for inhibiting insects
12/22/2005US20050283851 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/22/2005US20050283848 Expression of eukaryotic peptides in plant plastids
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283001 Preparation of canola protein isolate and use in aquaculture
12/22/2005US20050283000 Process for the production of a heterologous protein
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282855 Susceptibility gene for myocardial infarction, stroke, and PAOD; methods of treatment
12/22/2005US20050282770 Synthetic glycosulfopeptides and methods of synthesis thereof
12/22/2005US20050282763 Methods of treating bladder disorders
12/22/2005US20050282761 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/22/2005US20050282755 Compositions having antimicrobial activity and uses thereof
12/22/2005US20050282754 Peptides that mimic human hemochromatosis protein function that lowers the binding affinity of transferrin receptor for transferrin to reduce iron uptake and/or accumulation by a cell and nucleic acids encoding them
12/22/2005US20050282753 Bacteriocins and novel bacterial strains
12/22/2005US20050282752 IL-1ra variants
12/22/2005US20050282747 Methods and compositions for wound healing
12/22/2005US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators
12/22/2005US20050282745 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
12/22/2005US20050282743 Molecular interactions in cells
12/22/2005US20050282741 Peptides and their use to ameliorate cell death
1 ... 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 ... 2916